CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ

Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell

Recent advances in targeting the “undruggable” proteins: from drug

Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib

Alternative approaches to target Myc for cancer treatment

In vitro and in vivo efficacy of the novel oral proteasome

questions and strength and direction of the recommendations

Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell

In silico analysis identified miRNA‑based therapeutic agents

In vitro and in vivo efficacy of the novel oral proteasome

Frontiers Interplay Between Calcium and AMPK Signaling in Human